Key result
CRISPR is a flexible and scalable gene editing tool that is transforming molecular musculoskeletal research and holds potential for future clinical orthopaedic therapies.
CRISPR technology offers significant potential for advancing molecular musculoskeletal research and future clinical orthopaedic therapies.
Answers are grounded in this paper and cite their sources.
No immediate change to orthopaedic practice; leaves open CRISPR translation from musculoskeletal research to clinical therapies.
The ability to edit DNA at the nucleotide level using clustered regularly interspaced short palindromic repeats (CRISPR) systems is a relatively new investigative tool that is revolutionizing the analysis of many aspects of human health and disease, including orthopaedic disease. CRISPR, adapted for mammalian cell genome editing from a bacterial defence system, has been shown to be a flexible, programmable, scalable, and easy-to-use gene editing tool. Recent improvements increase the functionality of CRISPR through the engineering of specific elements of CRISPR systems, the discovery of new, naturally occurring CRISPR molecules, and modifications that take CRISPR beyond gene editing to the regulation of gene transcription and the manipulation of RNA. Here, the basics of CRISPR genome editing will be reviewed, including a description of how it has transformed some aspects of molecular musculoskeletal research, and will conclude by speculating what the future holds for the use of CRISPR-related treatments and therapies in clinical orthopaedic practice. Cite this article: Bone Joint Res 2020;9(7):351–359.
No takes yet. Share an insight, caveat, or question.
Jamie M. Fitzgerald (2020) conducted a review in Orthopaedic disease. CRISPR was evaluated. CRISPR is a flexible and scalable gene editing tool that is transforming molecular musculoskeletal research and holds potential for future clinical orthopaedic therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: